| Table 3: Effect of ulvan polysaccharide administration on plasma and ascites sialic
acid concentration in EAC-bearing. |
| Group |
Parameter |
Plasma sialic acid concentration(mg/100ml) |
Percent change |
Ascites sialic acid concentration
(mg/g protein) |
Percent change |
| EAC-bearing mice control (n=10) |
94.45 ±1.48 |
|
214.56 ±6.16 |
|
| EAC-bearing mice treated with ulvan polysaccharide (n=12) |
64.80 ±1.93** |
-31.39 |
180.12 ±5.65** |
-16.05 |
| F-probability |
P<0.001 |
P<0.001 |
| LSD at the 5% level |
5.24 |
17.45 |
| LSD at the 1% level |
7.15 |
23.80 |
|
| Data are expressed as mean ± standard error (SE).
*p<0.05: difference is significant; difference between two means is higher than value of LSD at the 5% level.
**p<0.01: difference is highly significant; difference between two means is higher than value of LSD at the 5% level. |
